BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16387402)

  • 1. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies.
    Isbrucker RA; Edwards JA; Wolz E; Davidovich A; Bausch J
    Food Chem Toxicol; 2006 May; 44(5):636-50. PubMed ID: 16387402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative urine metabolomics of mice treated with non-toxic and toxic oral doses of (-)-epigallocatechin-3-gallate.
    Hwang S; Koo I; Patterson AD; Lambert JD
    Food Funct; 2023 Oct; 14(20):9434-9445. PubMed ID: 37796030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of Epigallocatechin Gallate Administered With Different Nutritional Strategies in Healthy Volunteers.
    Andreu-Fernández V; Almeida Toledano L; Pizarro N; Navarro-Tapia E; Gómez-Roig MD; de la Torre R; García-Algar Ó
    Antioxidants (Basel); 2020 May; 9(5):. PubMed ID: 32438698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of epigallocatechin-3-gallate in treatment acute severe dermatitis in patients with cancer receiving radiotherapy: a phase I clinical trial.
    Xie J; Jia L; Xie P; Yin X; Zhu W; Zhao H; Wang X; Meng X; Xing L; Zhao H; Li X
    Sci Rep; 2023 Aug; 13(1):13865. PubMed ID: 37620508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the toxicity and pathogenicity of biocontrol agents in murine models, chicken embryos and dermal irritation in rabbits.
    Iris Betsabee OS; José Luis SS; Juan Arturo RS; Montserrat CS
    Toxicol Res (Camb); 2017 Mar; 6(2):188-198. PubMed ID: 30090489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 3: teratogenicity and reproductive toxicity studies in rats.
    Isbrucker RA; Edwards JA; Wolz E; Davidovich A; Bausch J
    Food Chem Toxicol; 2006 May; 44(5):651-61. PubMed ID: 16410036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of green tea extracts : a systematic review by the US Pharmacopeia.
    Sarma DN; Barrett ML; Chavez ML; Gardiner P; Ko R; Mahady GB; Marles RJ; Pellicore LS; Giancaspro GI; Low Dog T
    Drug Saf; 2008; 31(6):469-84. PubMed ID: 18484782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins.
    Galati G; Lin A; Sultan AM; O'Brien PJ
    Free Radic Biol Med; 2006 Feb; 40(4):570-80. PubMed ID: 16458187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis).
    Bonkovsky HL
    Ann Intern Med; 2006 Jan; 144(1):68-71. PubMed ID: 16389263
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatotoxicity from green tea: a review of the literature and two unpublished cases.
    Mazzanti G; Menniti-Ippolito F; Moro PA; Cassetti F; Raschetti R; Santuccio C; Mastrangelo S
    Eur J Clin Pharmacol; 2009 Apr; 65(4):331-41. PubMed ID: 19198822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of toxicity of green tea catechins with 90-day dietary administration to F344 rats.
    Takami S; Imai T; Hasumura M; Cho YM; Onose J; Hirose M
    Food Chem Toxicol; 2008 Jun; 46(6):2224-9. PubMed ID: 18400353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute liver failure induced by green tea extracts: case report and review of the literature.
    Molinari M; Watt KD; Kruszyna T; Nelson R; Walsh M; Huang WY; Nashan B; Peltekian K
    Liver Transpl; 2006 Dec; 12(12):1892-5. PubMed ID: 17133573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice.
    Lambert JD; Kennett MJ; Sang S; Reuhl KR; Ju J; Yang CS
    Food Chem Toxicol; 2010 Jan; 48(1):409-16. PubMed ID: 19883714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Green tea polyphenol (-)-epigallocatechin-3-gallate triggered hepatotoxicity in mice: responses of major antioxidant enzymes and the Nrf2 rescue pathway.
    Wang D; Wang Y; Wan X; Yang CS; Zhang J
    Toxicol Appl Pharmacol; 2015 Feb; 283(1):65-74. PubMed ID: 25585349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated dose studies with pure Epigallocatechin-3-gallate demonstrated dose and route dependant hepatotoxicity with associated dyslipidemia.
    Ramachandran B; Jayavelu S; Murhekar K; Rajkumar T
    Toxicol Rep; 2016; 3():336-345. PubMed ID: 28959554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro toxicity of epigallocatechin gallate in rat liver mitochondria and hepatocytes.
    Kucera O; Mezera V; Moravcova A; Endlicher R; Lotkova H; Drahota Z; Cervinkova Z
    Oxid Med Cell Longev; 2015; 2015():476180. PubMed ID: 25918582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 28-Day oral (gavage) toxicity studies of green tea catechins prepared for beverages in rats.
    Chengelis CP; Kirkpatrick JB; Regan KS; Radovsky AE; Beck MJ; Morita O; Tamaki Y; Suzuki H
    Food Chem Toxicol; 2008 Mar; 46(3):978-89. PubMed ID: 18086511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project 1.
    Kuriyama S; Hozawa A; Ohmori K; Shimazu T; Matsui T; Ebihara S; Awata S; Nagatomi R; Arai H; Tsuji I
    Am J Clin Nutr; 2006 Feb; 83(2):355-61. PubMed ID: 16469995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption, distribution, elimination of tea polyphenols in rats.
    Chen L; Lee MJ; Li H; Yang CS
    Drug Metab Dispos; 1997 Sep; 25(9):1045-50. PubMed ID: 9311619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent functionality and toxicity of green tea polyphenols in experimental rodents.
    Murakami A
    Arch Biochem Biophys; 2014 Sep; 557():3-10. PubMed ID: 24814373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.